Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Starkickeron Feb 16, 2024 11:47am
121 Views
Post# 35884292

RE:I fell for the Bullcrap

RE:I fell for the BullcrapSorry to hear that. Hopefully you get some of your losses back one way or another. Yes, most of the supposed information on here is pure speculation and not helpful, even dangerous. Most of the correct info can be found through simple google searches, but the ridiculous SP predictions and partner speculation put forth here is harmful to investors who believe it. Otherwise, LABS would be swarming with institutional investors, which it's not for obvious reasons. At the moment, LABS has just three very small institutional investors and is part of just one ETF so hardly a groundswell of momentum. 
<< Previous
Bullboard Posts
Next >>